Showing 1 - 7 results of 7 for search 'Jelle Adelmeijer', query time: 0.03s
Refine Results
-
1
Abnormal hemostatic function one year after orthotopic liver transplantation can be fully attributed to endothelial cell activation [v1; ref status: indexed, http://f1000r.es/3ah] by Freeha Arshad, Jelle Adelmeijer, Hans Blokzijl, Aad van den Berg, Robert Porte, Ton Lisman
Published 2014-05-01
Article -
2
Abnormal hemostatic function one year after orthotopic liver transplantation can be fully attributed to endothelial cell activation [v2; ref status: indexed, http://f1000r.es/40n] by Freeha Arshad, Jelle Adelmeijer, Hans Blokzijl, Aad van den Berg, Robert Porte, Ton Lisman
Published 2014-07-01
Article -
3
Plasma levels of circulating DNA are associated with outcome, but not with activation of coagulation in decompensated cirrhosis and ACLF by Annabel Blasi, Vishal C. Patel, Jelle Adelmeijer, Sarah Azarian, Fatima Aziz, Javier Fernández, William Bernal, Ton Lisman
Published 2019-09-01
Article -
4
Prothrombotic changes in patients with COVID‐19 are associated with disease severity and mortality by Fien A. vonMeijenfeldt, Sebastian Havervall, Jelle Adelmeijer, Annika Lundström, Ann‐Sofie Rudberg, Maria Magnusson, Nigel Mackman, Charlotte Thalin, Ton Lisman
Published 2021-01-01
Article -
5
Extended hypothermic oxygenated machine perfusion enables ex situ preservation of porcine livers for up to 24 hours by Isabel M.A. Brüggenwirth, Otto B. van Leeuwen, Yvonne de Vries, Silke B. Bodewes, Jelle Adelmeijer, Janneke Wiersema-Buist, Ton Lisman, Paulo N. Martins, Vincent E. de Meijer, Robert J. Porte
Published 2020-04-01
Article -
6
Aggravation of fibrin deposition and microthrombus formation within the graft during kidney transplantation by Tamar A. J. van den Berg, Marius C. van den Heuvel, Janneke Wiersema-Buist, Jelle Adelmeijer, Gertrude J. Nieuwenhuijs-Moeke, Ton Lisman, Stephan J. L. Bakker, Harry van Goor, TransplantLines Investigators, Robert A. Pol
Published 2021-09-01
Article -
7
Prolonged hypothermic machine perfusion enables daytime liver transplantation – an IDEAL stage 2 prospective clinical trialResearch in context by Isabel M.A. Brüggenwirth, Veerle A. Lantinga, Bianca Lascaris, Adam M. Thorne, Mark Meerdink, Ruben H. de Kleine, Hans Blokzijl, Aad P. van den Berg, Koen M.E.M. Reyntjens, Ton Lisman, Robert J. Porte, Vincent E. de Meijer, Vincent E. de Meijer, Isabel M.A. Brüggenwirth, Veerle A. Lantinga, Cyril Moers, Diethard Monbaliu, Sijbrand H. Hofker, Jan Bottema, Hildegaard S. Franke, Marieke T. de Boer, Anne Loes van den Boom, Carlijn I. Buis, Suomi M.G. Fouraschen, Frederik J.H. Hoogwater, Vincent E. de Meijer, Joost M. Klaase, Ruben H.J. de Kleine, Mark Meerdink, Maarten W. Nijkamp, Robert J. Porte, A. Michel Rayar, Aad P. van den Berg, Hans Blokzijl, Frans J.C. Cuperus, Frans van der Heide, Frederike G.I. van Vilsteren, Ilhama F. Abbasova, Meine H. Fernhout, Peter Meyer, Ernesto R.R. Muskiet, Koen M.E.M. Reyntjens, Jaap J. Vos, Miriam Zeillemaker, Isabel M.A. Brüggenwirth, Martijn P.D. Haring, Veerle A. Lantinga, Bianca Lascaris, Carol C. Pamplona, Adam M. Thorne, Vivianne Veenma, Otto B. van Leeuwen, Silke B. Bodewes, Ton Lisman, Jelle Adelmeijer, Janneke Wiersema-Buist, Marius van den Heuvel
Published 2024-02-01
Article